Sigrid Therapeutics
Quotes
Share:
Subscribe:

Sana Alajmovic CEO Sigrid Therapeutics

Mon, Sep 02, 2024 08:00 CET

Medium resolution

Original resolution

Subscribe

Related Releases

Sigrid Therapeutics Secures US Patent for Groundbreaking SiPore[®] Technology in Blood Sugar Management Mon, Dec 02, 2024 08:30 CET

Sigrid Therapeutics Announces Last Patient Last Visit in SHINE Clinical Trial Evaluating SiPore21® Gel for Sustained Blood Sugar Control Mon, Nov 04, 2024 08:30 CET

Sigrid Therapeutics Completes Enrollment in SHINE to Evaluate SiPore21® Gel for Sustained Blood Sugar and Weight Management Tue, Jul 30, 2024 08:30 CET